Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Name: Adaptive Biotechnologies Corp: Is Infosys Ltd. worth buying?
Item: Adaptive Biotechnologies Corp
Rating: 1.86583325
Author: Trendlyne DVM scores

Momentum Trap

about

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

18.04 -0.03 (-0.17%)

201.67% Gain from 52W Low

1.9M

XNAS Volume

XNAS 14 Jan, 2026 4:30 PM (EST)

Low Financial Strength

33.3 / 100

Expensive Valuation

9.0 / 100

Technically Bullish

73.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 11%

7 analysts

Adaptive biotech Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptive biotech Corp Live Stock Price Today, Share Analysis and Chart

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, ...

201.67% Gain from 52W Low

SWOT Analysis

Adaptive biotech Corp Live Price Chart